Additional file 2: of Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial

Bellingan, Geoff; Brealey, David; Mancebo, Jordi; Mercat, Alain; Patroniti, NicolĂ˛; PettilĂ¤, Ville; Quintel, Michael; Vincent, Jean-Louis; Maksimow, Mikael; Jalkanen, Markku; Piippo, Ilse; Ranieri, V.

doi:10.6084/m9.figshare.c.3929275_D2.v1

13063_2017_2234_MOESM2_ESM.pdf (403.03 kB)

Additional file 2: of Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial

journal contribution

posted on 2017-11-13, 05:00 authored by Geoff Bellingan, David Brealey, Jordi Mancebo, Alain Mercat, NicolĂ˛ Patroniti, Ville PettilĂ¤, Michael Quintel, Jean-Louis Vincent, Mikael Maksimow, Markku Jalkanen, Ilse Piippo, V. Ranieri

List of Ethical Committee approvals already in place. (PDF 403Â kb)

Funding

Faron Pharmaceuticals

History

Usage metrics

Keywords

Interferon ARDS Vascular leakage CD73

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial

Funding

Faron Pharmaceuticals

History

Usage metrics

Categories

Keywords

Licence

Exports